Skip to main content

Gamida Cell Ltd.

GMDADelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001600847

Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Gamida Cell Ltd. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of GMDA: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7370−3
Shares25.8M24.5M−1.28M (−5.0%)
Value$208.5M$157.0M−$51.5M (−24.7%)

New holders (14)

Institutions that held Gamida Cell Ltd. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to GMDA in Q2 2021
InstitutionSharesValue% of portfolio
Laird Norton Trust Company, LLC529,103$3.39M0.35%
D. E. Shaw & Co., Inc.139,440$894.0K0.00%
HRT Financial LP78,277$501.0K0.00%
Two Sigma Investments, LP62,587$401.0K0.00%
Susquehanna International Group, LLP52,690$338.0K0.00%
Platform Technology Partners45,375$291.0K0.12%
Trexquant Investment LP13,969$90.0K0.01%
XTX Topco Ltd13,141$84.0K0.03%
ExodusPoint Capital Management, LP12,600$81.0K0.00%
ProShare Advisors LLC10,637$68.0K0.00%
Advisory Services Network, LLC1,600$10.0K0.00%
Simplex Trading, LLC1,409$9.00K0.00%
Mirae Asset Global Investments Co., Ltd.962$6.00K0.00%
Altshuler Shaham Ltd532$3.00K0.00%

Sold out (17)

Institutions that held Gamida Cell Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.